Visit Taconic at the Merck Tech Symposium!

For more than 20 years, Amanda Denu has been instrumental in supporting researchers worldwide with their in vivo model needs. Through her dedication to fostering an effective collaboration between Taconic and Merck, and her ability to build strong, lasting relationships, she has assisted investigators in achieving their research goals and driving progress in their therapeutic areas.

Dr. Laura Griffin has been working with preclinical models for a decade and is experienced in choosing appropriate models for various research applications. She obtained her PhD in Food Science and Technology at Virginia Tech, where she focused on the mechanisms by which dietary bioactive compounds influence the onset of metabolic syndrome using preclinical models. As a postdoctoral fellow at the Plants for Human Health Institute, her research shifted to focus on the impact of the gut microbiome on the metabolism of bioactive compounds. In addition to her expertise in metabolic diseases in preclinical models, Dr. Griffin is also versed in laboratory animal diets and their usage in preclinical applications.